Tapewire

Nasdaq · USD

TTWO

TAKE TWO INTERACTIVE SOFTWARE INC

Export transactions ↓
Tapewire entity
3076
SEC CIK
0000946581
Parsed reports
505

Last 12 months

Inside the activity.

0 purchase rows · 95 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202504
Jan 202602
Feb 202604
Mar 2026010
Apr 202602
May 2026012
Jun 2026031
Jul 202602
Aug 2026015
Sep 202608
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 30, 2025 Filed Jun 3, 2025 20:18 UTC
Slatoff KarlPresident
SaleCommon Stock 157,749 $225.97 $35,645,752.79
Disclosure

SEC source: 0001127602-25-016453 · form4.xml · nonDerivative · entry 2

Slatoff Karl · CIK 0001427810 · President

10b5-1 filing: Plan reported

Ownership: Indirect · By ZMC Advisors, L.P.

Disclosed balance after: 1,214,404

F2 · kind: All of the sales reported in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted on November 12, 2024 by ZMC related to the vesting of restricted units granted pursuant to the Management Agreement.

F3 · shares: These transactions are reported on separate lines due to the range of the sale prices.

F4 · shares: On May 30, 2025, 515,863 restricted units previously granted to ZMC vested. The reported sale transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on November 12, 2024 by ZMC, to satisfy the tax obligations of the partners of ZMC upon the vesting of such restricted units.

F6 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $225.35 to $226.35, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer

Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:18 UTC
Slatoff KarlPresident
SaleCommon Stock 50,935 $224.97 $11,458,811.30
Disclosure

SEC source: 0001127602-25-016453 · form4.xml · nonDerivative · entry 1

Slatoff Karl · CIK 0001427810 · President

10b5-1 filing: Plan reported

Ownership: Indirect · By ZMC Advisors, L.P.

Disclosed balance after: 1,372,153

F1 · security: EXPLANATORY NOTE: This Form 4 relates to (i) the vesting of 515,863 restricted units previously granted to ZMC Advisors, L.P. ("ZMC") on June 1, 2022, June 1, 2023 and June 3, 2024 under the Management Agreement, dated effective May 23, 2022, between the issuer and ZMC (the "Management Agreement"), and the sale of shares of Common Stock by ZMC, in order to satisfy the tax obligations arising from such vesting, pursuant to a Rule 10b5-1 trading plan adopted on November 12, 2024 by ZMC, (ii) the distribution by ZMC to certain of its employees of 299,202 shares of Common Stock received by ZMC upon such vesting in accordance with the customary historical practices of ZMC, and (iii) the annual grant of restricted stock units to ZMC on June 2, 2025, in each case as further described below.

F2 · kind: All of the sales reported in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted on November 12, 2024 by ZMC related to the vesting of restricted units granted pursuant to the Management Agreement.

F3 · shares: These transactions are reported on separate lines due to the range of the sale prices.

F4 · shares: On May 30, 2025, 515,863 restricted units previously granted to ZMC vested. The reported sale transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on November 12, 2024 by ZMC, to satisfy the tax obligations of the partners of ZMC upon the vesting of such restricted units.

F5 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $224.34 to $225.33, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer

Read SEC document
May 28, 2025 Filed May 30, 2025 20:38 UTC GrantCommon Stock 262 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-016058 · form4.xml · nonDerivative · entry 1

Dornemann Michael · CIK 0001296020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,694

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was May 28, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to May 28, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Annual Report on Form 10-K.

Read SEC document
May 28, 2025 Filed May 30, 2025 20:16 UTC GrantCommon Stock 334 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-016035 · form4.xml · nonDerivative · entry 1

GORDON WILLIAM B · CIK 0001229590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,573

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). Includes 262 shares of restricted stock that vest on the first anniversary of the Pricing Date (as defined below) and 72 shares of common stock granted in lieu of cash compensation at the election of the Reporting Person, which shares were fully vested upon grant. As provided by the terms of the Program and the Stock Plan, (i) the grant date was May 28, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to May 28, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Annual Report on Form 10-K.

Read SEC document
May 28, 2025 Filed May 30, 2025 20:34 UTC
Moses Jon JDirector
GrantCommon Stock 262 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-016056 · form4.xml · nonDerivative · entry 1

Moses Jon J · CIK 0001395704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,647

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was May 28, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to May 28, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Annual Report on Form 10-K.

Read SEC document
May 28, 2025 Filed May 30, 2025 20:31 UTC GrantCommon Stock 262 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-016054 · form4.xml · nonDerivative · entry 1

Sheresky Michael · CIK 0001395208 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,140

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was May 28, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to May 28, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Annual Report on Form 10-K.

Read SEC document
May 28, 2025 Filed May 30, 2025 20:29 UTC
Tolson SusanDirector
GrantCommon Stock 262 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-016052 · form4.xml · nonDerivative · entry 1

Tolson Susan · CIK 0001603241 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,901

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was May 28, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to May 28, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Annual Report on Form 10-K.

Read SEC document
May 28, 2025 Filed May 30, 2025 20:26 UTC GrantCommon Stock 373 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-016050 · form4.xml · nonDerivative · entry 1

Srinivasan LaVerne Evans · CIK 0001701630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,026

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was May 28, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to May 28, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Annual Report on Form 10-K.

Read SEC document
May 28, 2025 Filed May 30, 2025 20:24 UTC GrantCommon Stock 262 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-016048 · form4.xml · nonDerivative · entry 1

HERNANDEZ ROLAND A · CIK 0001194703 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,506

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was May 28, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to May 28, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Annual Report on Form 10-K.

Read SEC document
May 28, 2025 Filed May 30, 2025 20:22 UTC
Viera Paul EDirector
GrantCommon Stock 356 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-016046 · form4.xml · nonDerivative · entry 1

Viera Paul E · CIK 0001741087 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,591

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). Includes 262 shares of restricted stock that vest on the first anniversary of the Pricing Date (as defined below) and 94 shares of common stock granted in lieu of cash compensation at the election of the Reporting Person, which shares were fully vested upon grant. As provided by the terms of the Program and the Stock Plan, (i) the grant date was May 28, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to May 28, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Annual Report on Form 10-K.

Read SEC document
May 28, 2025 Filed May 30, 2025 20:19 UTC GrantCommon Stock 367 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-016040 · form4.xml · nonDerivative · entry 1

Siminoff Ellen F · CIK 0001386430 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,835

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). Includes 262 shares of restricted stock that vest on the first anniversary of the Pricing Date (as defined below) and 105 shares of common stock granted in lieu of cash compensation at the election of the Reporting Person, which shares were fully vested upon grant. As provided by the terms of the Program and the Stock Plan, (i) the grant date was May 28, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to May 28, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Annual Report on Form 10-K.

F2 · balance_after: Total reflects 1,658 shares previously transferred from Insider's direct ownership to the D&E Living Trust in a transfer exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

Read SEC document
March 06, 2025 Filed Mar 7, 2025 21:07 UTC SaleCommon Stock 173 $214.20 $37,056.60
Disclosure

SEC source: 0001127602-25-008686 · form4.xml · nonDerivative · entry 1

Sheresky Michael · CIK 0001395208 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,878

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2024 by the Reporting Person and was effected to satisfy the Reporting Person's tax obligations upon the vesting of previously granted shares of restricted stock.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:28 UTC
Goldstein LainieChief Financial Officer
SaleCommon Stock 829 $211.24 $175,117.96
Disclosure

SEC source: 0001127602-25-008310 · form4.xml · nonDerivative · entry 1

Goldstein Lainie · CIK 0001399513 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 310,163

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 "sell to cover" election made by the Reporting Person for the sole purpose to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted restricted units. This sale does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes (i) 96,646 shares of Common Stock, (ii) 27,933 unvested time-based restricted stock units and (iii) 185,584 unvested performance-based restricted stock units. Such unvested awards will vest, or fail to vest, in accordance with the terms of the applicable award agreements.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:25 UTC
Emerson Daniel PChief Legal Officer
SaleCommon Stock 577 $211.24 $121,885.48
Disclosure

SEC source: 0001127602-25-008307 · form4.xml · nonDerivative · entry 1

Emerson Daniel P · CIK 0001623654 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 148,184

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 "sell to cover" election made by the Reporting Person for the sole purpose to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted restricted units. This sale does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes (i) 1,652 shares of Common Stock, (ii) 19,172 unvested time-based restricted stock units and (iii) 127,360 unvested performance-based restricted stock units. Such unvested awards will vest, or fail to vest, in accordance with the terms of the applicable award agreements.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:16 UTC
Slatoff KarlPresident
SaleCommon Stock 678 $210.16 $142,488.48
Disclosure

SEC source: 0001127602-25-007113 · form4.xml · nonDerivative · entry 4

Slatoff Karl · CIK 0001427810 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Sale of shares pursuant to Rule 10b5-1 trading plan adopted on November 27, 2024.

F5 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $209.81 to $210.48, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:16 UTC
Slatoff KarlPresident
SaleCommon Stock 3,220 $208.92 $672,722.40
Disclosure

SEC source: 0001127602-25-007113 · form4.xml · nonDerivative · entry 3

Slatoff Karl · CIK 0001427810 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 678

F1 · shares: Sale of shares pursuant to Rule 10b5-1 trading plan adopted on November 27, 2024.

F4 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $208.80 to $209.23, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:16 UTC
Slatoff KarlPresident
SaleCommon Stock 23,327 $208.18 $4,856,214.86
Disclosure

SEC source: 0001127602-25-007113 · form4.xml · nonDerivative · entry 2

Slatoff Karl · CIK 0001427810 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,898

F1 · shares: Sale of shares pursuant to Rule 10b5-1 trading plan adopted on November 27, 2024.

F3 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $207.79 to $208.75, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 21:16 UTC
Slatoff KarlPresident
SaleCommon Stock 6,487 $207.32 $1,344,884.84
Disclosure

SEC source: 0001127602-25-007113 · form4.xml · nonDerivative · entry 1

Slatoff Karl · CIK 0001427810 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,225

F1 · shares: Sale of shares pursuant to Rule 10b5-1 trading plan adopted on November 27, 2024.

F2 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $206.75 to $207.71, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:32 UTC
Moses Jon JDirector
GrantCommon Stock 310 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-005503 · form4.xml · nonDerivative · entry 1

Moses Jon J · CIK 0001395704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,385

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was February 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to February 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:35 UTC GrantCommon Stock 310 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-005507 · form4.xml · nonDerivative · entry 1

Dornemann Michael · CIK 0001296020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,432

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was February 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to February 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:30 UTC GrantCommon Stock 310 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-005500 · form4.xml · nonDerivative · entry 1

Sheresky Michael · CIK 0001395208 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,051

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was February 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to February 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:29 UTC
Tolson SusanDirector
GrantCommon Stock 310 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-005497 · form4.xml · nonDerivative · entry 1

Tolson Susan · CIK 0001603241 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,639

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was February 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to February 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:27 UTC GrantCommon Stock 443 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-005491 · form4.xml · nonDerivative · entry 1

Srinivasan LaVerne Evans · CIK 0001701630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,653

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was February 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to February 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:23 UTC
Viera Paul EDirector
GrantCommon Stock 422 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-005485 · form4.xml · nonDerivative · entry 1

Viera Paul E · CIK 0001741087 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,235

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). Includes 310 shares of restricted stock that vest on the first anniversary of the Pricing Date (as defined below) and 112 shares of common stock granted in lieu of cash compensation at the election of the Reporting Person, which shares were fully vested upon grant. As provided by the terms of the Program and the Stock Plan, (i) the grant date was February 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to February 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:25 UTC GrantCommon Stock 310 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-005488 · form4.xml · nonDerivative · entry 1

HERNANDEZ ROLAND A · CIK 0001194703 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,244

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was February 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to February 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:21 UTC GrantCommon Stock 395 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-005482 · form4.xml · nonDerivative · entry 1

GORDON WILLIAM B · CIK 0001229590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,239

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). Includes 310 shares of restricted stock that vest on the first anniversary of the Pricing Date (as defined below) and 85 shares of common stock granted in lieu of cash compensation at the election of the Reporting Person, which shares were fully vested upon grant. As provided by the terms of the Program and the Stock Plan, (i) the grant date was February 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to February 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:16 UTC GrantCommon Stock 435 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-005479 · form4.xml · nonDerivative · entry 1

Siminoff Ellen F · CIK 0001386430 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,126

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). Includes 310 shares of restricted stock that vest on the first anniversary of the Pricing Date (as defined below) and 125 shares of common stock granted in lieu of cash compensation at the election of the Reporting Person, which shares were fully vested upon grant. As provided by the terms of the Program and the Stock Plan, (i) the grant date was February 14, 2025; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to February 14, 2025 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:07 UTC
Emerson Daniel PChief Legal Officer
SaleCommon Stock 618 $188.35 $116,400.30
Disclosure

SEC source: 0001127602-24-028662 · form4.xml · nonDerivative · entry 2

Emerson Daniel P · CIK 0001623654 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 148,761

F2 · balance_after: Includes (i) 834 shares of Common Stock, (ii) 20,567 unvested time-based restricted stock units and (iii) 127,360 unvested performance-based restricted stock units. Such unvested awards will vest, or fail to vest, in accordance with the terms of the applicable award agreements.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:10 UTC
Goldstein LainieChief Financial Officer
SaleCommon Stock 1,131 $187.64 $212,220.84
Disclosure

SEC source: 0001127602-24-028666 · form4.xml · nonDerivative · entry 1

Goldstein Lainie · CIK 0001399513 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 310,992

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 "sell to cover" election made by the Reporting Person for the sole purpose to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted restricted units. This sale does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes (i) 95,441 shares of Common Stock, (ii) 29,967 unvested time-based restricted stock units and (iii) 185,584 unvested performance-based restricted stock units. Such unvested awards will vest, or fail to vest, in accordance with the terms of the applicable award agreements.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:07 UTC
Emerson Daniel PChief Legal Officer
SaleCommon Stock 777 $187.64 $145,796.28
Disclosure

SEC source: 0001127602-24-028662 · form4.xml · nonDerivative · entry 1

Emerson Daniel P · CIK 0001623654 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 149,379

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 "sell to cover" election made by the Reporting Person for the sole purpose to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted restricted units. This sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
November 19, 2024 Filed Nov 21, 2024 21:17 UTC
ZELNICK STRAUSSDirector · Chairman, CEO
SaleCommon Stock 20,000 $184.70 $3,694,000.00
Disclosure

SEC source: 0001127602-24-027809 · form4.xml · nonDerivative · entry 1

ZELNICK STRAUSS · CIK 0001223489 · Director · Chairman, CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wendy Jay Belzberg 2012 Family Trust

Disclosed balance after: 39,051

F1 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $184.65 to $184.81, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

Read SEC document
November 15, 2024 Filed Nov 18, 2024 21:21 UTC
Tolson SusanDirector
GrantCommon Stock 363 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-027498 · form4.xml · nonDerivative · entry 1

Tolson Susan · CIK 0001603241 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,329

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was November 14, 2024; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to November 14, 2024 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:26 UTC
Moses Jon JDirector
GrantCommon Stock 363 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-027502 · form4.xml · nonDerivative · entry 1

Moses Jon J · CIK 0001395704 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,075

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was November 14, 2024; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to November 14, 2024 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:23 UTC GrantCommon Stock 363 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-027500 · form4.xml · nonDerivative · entry 1

Sheresky Michael · CIK 0001395208 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,741

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was November 14, 2024; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to November 14, 2024 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:18 UTC GrantCommon Stock 518 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-027496 · form4.xml · nonDerivative · entry 1

Srinivasan LaVerne Evans · CIK 0001701630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,210

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was November 14, 2024; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to November 14, 2024 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:14 UTC
Viera Paul EDirector
GrantCommon Stock 494 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-027489 · form4.xml · nonDerivative · entry 1

Viera Paul E · CIK 0001741087 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,813

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). Includes 363 shares of restricted stock that vest on the first anniversary of the Pricing Date (as defined below) and 131 shares of common stock granted in lieu of cash compensation at the election of the Reporting Person, which shares were fully vested upon grant. As provided by the terms of the Program and the Stock Plan, (i) the grant date was November 14, 2024; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to November 14, 2024 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:16 UTC GrantCommon Stock 363 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-027491 · form4.xml · nonDerivative · entry 1

HERNANDEZ ROLAND A · CIK 0001194703 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,934

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was November 14, 2024; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to November 14, 2024 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:12 UTC GrantCommon Stock 509 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-027487 · form4.xml · nonDerivative · entry 1

Siminoff Ellen F · CIK 0001386430 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,691

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). Includes 363 shares of restricted stock that vest on the first anniversary of the Pricing Date (as defined below) and 146 shares of common stock granted in lieu of cash compensation at the election of the Reporting Person, which shares were fully vested upon grant. As provided by the terms of the Program and the Stock Plan, (i) the grant date was November 14, 2024; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to November 14, 2024 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:10 UTC GrantCommon Stock 463 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-027484 · form4.xml · nonDerivative · entry 1

GORDON WILLIAM B · CIK 0001229590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,844

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). Includes 363 shares of restricted stock that vest on the first anniversary of the Pricing Date (as defined below) and 100 shares of common stock granted in lieu of cash compensation at the election of the Reporting Person, which shares were fully vested upon grant. As provided by the terms of the Program and the Stock Plan, (i) the grant date was November 14, 2024; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to November 14, 2024 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:08 UTC GrantCommon Stock 363 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-027479 · form4.xml · nonDerivative · entry 1

Dornemann Michael · CIK 0001296020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,122

F1 · shares: Represents the acquisition of shares pursuant to a grant of restricted common stock pursuant to the Director compensation program (the "Program") and the Issuer's 2017 Stock Incentive Plan (the "Stock Plan"). The shares of restricted stock vest on the first anniversary of the Pricing Date (as defined below). As provided by the terms of the Program and the Stock Plan, (i) the grant date was November 14, 2024; and (ii) the number of shares were determined based on the dollar value of the award and the average of the closing prices of the common stock on the thirty trading days prior to November 14, 2024 (the "Pricing Date"), the fifth trading day following the filing of the Issuer's Quarterly Report on Form 10-Q.

Read SEC document
November 08, 2024 Filed Nov 12, 2024 22:54 UTC SaleCommon Stock 2,000 $179.17 $358,340.00
Disclosure

SEC source: 0001127602-24-027098 · form4.xml · nonDerivative · entry 1

Srinivasan LaVerne Evans · CIK 0001701630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,692

Read SEC document
November 08, 2024 Filed Nov 12, 2024 22:52 UTC
Goldstein LainieChief Financial Officer
SaleCommon Stock 2,560 $178.83 $457,799.94
Disclosure

SEC source: 0001127602-24-027096 · form4.xml · nonDerivative · entry 5

Goldstein Lainie · CIK 0001399513 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 312,123

F5 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $178.17 to $179.17, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

F6 · balance_after: Includes (i) 94,538 shares of Common Stock, (ii) 32,001 unvested time-based restricted stock units and (iii) 185,584 unvested performance-based restricted stock units. Such unvested awards will vest, or fail to vest, in accordance with the terms of the applicable award agreements.

Read SEC document
November 08, 2024 Filed Nov 12, 2024 22:52 UTC
Goldstein LainieChief Financial Officer
SaleCommon Stock 1,648 $176.94 $291,600.42
Disclosure

SEC source: 0001127602-24-027096 · form4.xml · nonDerivative · entry 4

Goldstein Lainie · CIK 0001399513 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 314,683

F4 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $176.65 to $177.16, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

Read SEC document
November 08, 2024 Filed Nov 12, 2024 22:52 UTC
Goldstein LainieChief Financial Officer
SaleCommon Stock 9,358 $175.79 $1,645,073.70
Disclosure

SEC source: 0001127602-24-027096 · form4.xml · nonDerivative · entry 3

Goldstein Lainie · CIK 0001399513 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,331

F3 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $175.51 to $176.41, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

Read SEC document
November 08, 2024 Filed Nov 12, 2024 22:52 UTC
Goldstein LainieChief Financial Officer
SaleCommon Stock 18,247 $175.04 $3,193,867.29
Disclosure

SEC source: 0001127602-24-027096 · form4.xml · nonDerivative · entry 2

Goldstein Lainie · CIK 0001399513 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,689

F2 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $174.51 to $175.49, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

Read SEC document
November 08, 2024 Filed Nov 12, 2024 22:52 UTC
Goldstein LainieChief Financial Officer
SaleCommon Stock 18,258 $173.98 $3,176,565.18
Disclosure

SEC source: 0001127602-24-027096 · form4.xml · nonDerivative · entry 1

Goldstein Lainie · CIK 0001399513 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 343,936

F1 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $173.50 to $174.50, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

Read SEC document
November 08, 2024 Filed Nov 12, 2024 22:49 UTC
Emerson Daniel PChief Legal Officer
SaleCommon Stock 2,500 $179.17 $447,925.00
Disclosure

SEC source: 0001127602-24-027094 · form4.xml · nonDerivative · entry 2

Emerson Daniel P · CIK 0001623654 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,156

F2 · balance_after: Includes (i) 834 shares of Common Stock, (ii) 21,962 unvested time-based restricted stock units and (iii) 127,360 unvested performance-based restricted stock units. Such unvested awards will vest, or fail to vest, in accordance with the terms of the applicable award agreements.

Read SEC document
November 08, 2024 Filed Nov 13, 2024 21:29 UTC
ZELNICK STRAUSSDirector · Chairman, CEO
SaleCommon Stock 10,984 $176.54 $1,939,072.52
Disclosure

SEC source: 0001127602-24-027220 · form4.xml · nonDerivative · entry 8

ZELNICK STRAUSS · CIK 0001223489 · Director · Chairman, CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wendy Jay Belzberg 2012 Family Trust

Disclosed balance after: 59,051

F7 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $176.14 to $176.85, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

F8 · balance_after: Represents 59,051 shares of Common Stock held by the Wendy Jay Belzberg 2012 Family Trust (such securities are indirectly held by Mr. Zelnick). Mr. Zelnick disclaims beneficial ownership of the securities held by the Wendy Jay Belzberg 2012 Family Trust except to the extent of his pecuniary interest therein.

Read SEC document
November 08, 2024 Filed Nov 13, 2024 21:29 UTC
ZELNICK STRAUSSDirector · Chairman, CEO
SaleCommon Stock 1,116 $175.80 $196,195.81
Disclosure

SEC source: 0001127602-24-027220 · form4.xml · nonDerivative · entry 7

ZELNICK STRAUSS · CIK 0001223489 · Director · Chairman, CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wendy Jay Belzberg 2012 Family Trust

Disclosed balance after: 70,035

F6 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $175.13 to $176.11, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

Read SEC document
November 08, 2024 Filed Nov 13, 2024 21:29 UTC
ZELNICK STRAUSSDirector · Chairman, CEO
SaleCommon Stock 400 $174.14 $69,657.00
Disclosure

SEC source: 0001127602-24-027220 · form4.xml · nonDerivative · entry 6

ZELNICK STRAUSS · CIK 0001223489 · Director · Chairman, CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wendy Jay Belzberg 2012 Family Trust

Disclosed balance after: 71,151

F5 · price: Represents a weighted average sales price of shares sold in multiple transactions at sales prices ranging from $173.81 to $174.71, inclusive. Upon request, the Reporting Person undertakes to provide the full sale information regarding the number of shares sold at each price increment to the Commission, the issuer or any security holder of the issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.